The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Acute therapies continue to report strong growth compared to chronic ones.
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
This unique record was made possible by collating hard copies of the books in a structured manner
This is a virtual event and the theme is `Transforming Healthcare beyond Covid’
It has planned an investment of over Rs 80 crore in the next five years
Since its inception, the company has either acquired or taken a majority stake in five companies
The transaction is anticipated to close in the first quarter of 2022
A team of experts at Fortis Gurugram conducted 3-dimensional mapping with the help of the new system Carto version 7 to precisely map the source of the arrhythmia. It was detected that the arrhythmia was coming from the conduction system i.e. body’s natural wiring.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
